Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 33, Issue 5, Pages 165-171
Publisher
Informa UK Limited
Online
2015-04-02
DOI
10.3109/07357907.2015.1019676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
- (2014) Yi Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer
- (2014) Xiaochun Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer stem cells and radioresistance
- (2014) Kiera Rycaj et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- miRNA dysregulation in cancer: towards a mechanistic understanding
- (2014) Jayanth Kumar Palanichamy et al. Frontiers in Genetics
- miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1
- (2013) X. Huang et al. CANCER RESEARCH
- Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma
- (2013) Shi-Yun Cui et al. MOLECULAR CANCER RESEARCH
- Early-Stage Non-Small Cell Lung Cancer: Surgery, Stereotactic Radiosurgery, and Individualized Adjuvant Therapy
- (2013) Sukhmani K. Padda et al. SEMINARS IN ONCOLOGY
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
- (2013) S Grosso et al. Cell Death & Disease
- Sphingosine-1-phosphate signaling in physiology and diseases
- (2012) Yoh Takuwa et al. BIOFACTORS
- Trinta anos de irradiação craniana profilática em pacientes com câncer de pulmão de pequenas células: uma meta-análise de ensaios clínicos randomizados
- (2012) Gustavo Arruda Viani et al. Jornal Brasileiro de Pneumologia
- MicroRNAs in the pathogenesis of malignant melanoma
- (2012) M. Glud et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN
- (2012) Zhi-Li Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma-their prognostic significance
- (2012) Koji Okudela et al. PATHOLOGY INTERNATIONAL
- Abnormal Hippocampal BDNF and miR-16 Expression Is Associated with Depression-Like Behaviors Induced by Stress during Early Life
- (2012) Mei Bai et al. PLoS One
- miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
- (2009) Elena Gallardo et al. CARCINOGENESIS
- Treatment Resistance in Stem Cells and Breast Cancer
- (2009) Bhuvanesh Dave et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2009) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Tissue Specific Cytotoxicity of Colon Cancer Cells Mediated by Nanoparticle-delivered Suicide Gene In vitro and In vivo
- (2008) G. Zhang et al. CLINICAL CANCER RESEARCH
- Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
- (2008) S. Ramalingam et al. ONCOLOGIST
- ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells
- (2008) Julie Douville et al. STEM CELLS AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search